ASX - By Stock
|
KZA |
Re:
Option 2 vs 3
|
|
yolt
|
71 |
18K |
0 |
15/11/23 |
15/11/23 |
ASX - By Stock
|
71
|
18K
|
0
|
|
ASX - By Stock
|
KZA |
Re:
Option 2 vs 3
|
|
yolt
|
71 |
18K |
0 |
15/11/23 |
15/11/23 |
ASX - By Stock
|
71
|
18K
|
0
|
|
ASX - By Stock
|
KZA |
Re:
Excellent interim DIPG data from PNOC
|
|
yolt
|
21 |
6.4K |
0 |
12/11/23 |
12/11/23 |
ASX - By Stock
|
21
|
6.4K
|
0
|
|
ASX - By Stock
|
KZA |
Re:
Excellent interim DIPG data from PNOC
|
|
yolt
|
21 |
6.4K |
2 |
12/11/23 |
12/11/23 |
ASX - By Stock
|
21
|
6.4K
|
2
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Notice of Annual General Meeting/Proxy Form
|
|
yolt
|
10 |
3.2K |
3 |
03/11/23 |
03/11/23 |
ASX - By Stock
|
10
|
3.2K
|
3
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Preliminary update from ongoing Phase 2 Study of Paxalisib
|
|
yolt
|
6 |
2.1K |
6 |
02/11/23 |
02/11/23 |
ASX - By Stock
|
6
|
2.1K
|
6
|
|
ASX - By Stock
|
KZA |
Re:
Unravelling glioblastoma’s secrets and harnessing two decades of progress
|
|
yolt
|
9 |
2.5K |
2 |
02/11/23 |
02/11/23 |
ASX - By Stock
|
9
|
2.5K
|
2
|
|
ASX - By Stock
|
KZA |
Re:
Option 2 vs 3
|
|
yolt
|
71 |
18K |
2 |
01/11/23 |
01/11/23 |
ASX - By Stock
|
71
|
18K
|
2
|
|
ASX - By Stock
|
KZA |
Re:
Option 2 vs 3
|
|
yolt
|
71 |
18K |
2 |
01/11/23 |
01/11/23 |
ASX - By Stock
|
71
|
18K
|
2
|
|
ASX - By Stock
|
KZA |
SEC Filing
|
|
yolt
|
3 |
976 |
2 |
27/10/23 |
27/10/23 |
ASX - By Stock
|
3
|
976
|
2
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Kazia announces Clinical Data at ESMO 2023 from EVT801 Study
|
|
yolt
|
2 |
1.0K |
5 |
24/10/23 |
24/10/23 |
ASX - By Stock
|
2
|
1.0K
|
5
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Change of AGM date
|
|
yolt
|
10 |
2.6K |
3 |
18/10/23 |
18/10/23 |
ASX - By Stock
|
10
|
2.6K
|
3
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Change of AGM date
|
|
yolt
|
10 |
2.6K |
7 |
18/10/23 |
18/10/23 |
ASX - By Stock
|
10
|
2.6K
|
7
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Kazia announces intention to voluntarily de-list from ASX
|
|
yolt
|
54 |
17K |
7 |
11/10/23 |
11/10/23 |
ASX - By Stock
|
54
|
17K
|
7
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Trading Halt
|
|
yolt
|
30 |
9.7K |
7 |
10/10/23 |
10/10/23 |
ASX - By Stock
|
30
|
9.7K
|
7
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Trading Halt
|
|
yolt
|
30 |
9.7K |
5 |
07/10/23 |
07/10/23 |
ASX - By Stock
|
30
|
9.7K
|
5
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Trading Halt
|
|
yolt
|
30 |
9.7K |
3 |
07/10/23 |
07/10/23 |
ASX - By Stock
|
30
|
9.7K
|
3
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Trading Halt
|
|
yolt
|
30 |
9.7K |
3 |
07/10/23 |
07/10/23 |
ASX - By Stock
|
30
|
9.7K
|
3
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Trading Halt
|
|
yolt
|
30 |
9.7K |
3 |
06/10/23 |
06/10/23 |
ASX - By Stock
|
30
|
9.7K
|
3
|
|
ASX - By Stock
|
KZA |
Re:
KZA Media Thread
|
|
yolt
|
2.0K |
621K |
5 |
03/10/23 |
03/10/23 |
ASX - By Stock
|
2.0K
|
621K
|
5
|
|
ASX - By Stock
|
KZA |
Re:
KZA Media Thread
|
|
yolt
|
2.0K |
621K |
2 |
02/10/23 |
02/10/23 |
ASX - By Stock
|
2.0K
|
621K
|
2
|
|
ASX - By Stock
|
KZA |
Re:
KZA Media Thread
|
|
yolt
|
2.0K |
621K |
4 |
30/09/23 |
30/09/23 |
ASX - By Stock
|
2.0K
|
621K
|
4
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Acceptance of late-breaking abstract of PNOC022 data
|
|
yolt
|
7 |
2.3K |
7 |
29/09/23 |
29/09/23 |
ASX - By Stock
|
7
|
2.3K
|
7
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Acceptance of late-breaking abstract of PNOC022 data
|
|
yolt
|
7 |
2.3K |
5 |
29/09/23 |
29/09/23 |
ASX - By Stock
|
7
|
2.3K
|
5
|
|
ASX - By Stock
|
KZA |
Re:
KZA Media Thread
|
|
yolt
|
2.0K |
621K |
3 |
28/09/23 |
28/09/23 |
ASX - By Stock
|
2.0K
|
621K
|
3
|
|
ASX - By Stock
|
KZA |
Re:
KZA Media Thread
|
|
yolt
|
2.0K |
621K |
2 |
28/09/23 |
28/09/23 |
ASX - By Stock
|
2.0K
|
621K
|
2
|
|
ASX - By Stock
|
KZA |
Re:
KZA Media Thread
|
|
yolt
|
2.0K |
621K |
5 |
22/09/23 |
22/09/23 |
ASX - By Stock
|
2.0K
|
621K
|
5
|
|
ASX - By Stock
|
KZA |
Re:
KZA Media Thread
|
|
yolt
|
2.0K |
621K |
8 |
21/09/23 |
21/09/23 |
ASX - By Stock
|
2.0K
|
621K
|
8
|
|
ASX - By Stock
|
KZA |
Re:
KZA Media Thread
|
|
yolt
|
2.0K |
621K |
5 |
20/09/23 |
20/09/23 |
ASX - By Stock
|
2.0K
|
621K
|
5
|
|
ASX - By Stock
|
KZA |
Re:
KZA Media Thread
|
|
yolt
|
2.0K |
621K |
6 |
15/09/23 |
15/09/23 |
ASX - By Stock
|
2.0K
|
621K
|
6
|
|
ASX - By Stock
|
KZA |
Re:
Ann: 2023 Corporate Governance Statement
|
|
yolt
|
22 |
6.4K |
2 |
05/09/23 |
05/09/23 |
ASX - By Stock
|
22
|
6.4K
|
2
|
|
ASX - By Stock
|
KZA |
Re:
Ann: 2023 Corporate Governance Statement
|
|
yolt
|
22 |
6.4K |
1 |
01/09/23 |
01/09/23 |
ASX - By Stock
|
22
|
6.4K
|
1
|
|
ASX - By Stock
|
KZA |
Re:
Examples of Suspicious Pricing Action
|
|
yolt
|
273 |
89K |
4 |
31/08/23 |
31/08/23 |
ASX - By Stock
|
273
|
89K
|
4
|
|
ASX - By Stock
|
KZA |
Re:
Examples of Suspicious Pricing Action
|
|
yolt
|
273 |
89K |
6 |
30/08/23 |
30/08/23 |
ASX - By Stock
|
273
|
89K
|
6
|
|
ASX - By Stock
|
KZA |
Re:
DIPG Panel Discussion
|
|
yolt
|
103 |
38K |
6 |
18/08/23 |
18/08/23 |
ASX - By Stock
|
103
|
38K
|
6
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Kazia announces change to Board of Directors
|
|
yolt
|
20 |
6.6K |
0 |
11/08/23 |
11/08/23 |
ASX - By Stock
|
20
|
6.6K
|
0
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Kazia announces change to Board of Directors
|
|
yolt
|
20 |
6.6K |
0 |
11/08/23 |
11/08/23 |
ASX - By Stock
|
20
|
6.6K
|
0
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Kazia announces change to Board of Directors
|
|
yolt
|
20 |
6.6K |
5 |
11/08/23 |
11/08/23 |
ASX - By Stock
|
20
|
6.6K
|
5
|
|
ASX - By Stock
|
PER |
Re:
James Garner AKA JG
|
|
yolt
|
190 |
49K |
1 |
09/08/23 |
09/08/23 |
ASX - By Stock
|
190
|
49K
|
1
|
|
ASX - By Stock
|
PER |
Re:
James Garner AKA JG
|
|
yolt
|
190 |
49K |
2 |
09/08/23 |
09/08/23 |
ASX - By Stock
|
190
|
49K
|
2
|
|
ASX - By Stock
|
PER |
Re:
James Garner AKA JG
|
|
yolt
|
190 |
49K |
0 |
09/08/23 |
09/08/23 |
ASX - By Stock
|
190
|
49K
|
0
|
|
ASX - By Stock
|
PER |
Re:
James Garner AKA JG
|
|
yolt
|
190 |
49K |
2 |
08/08/23 |
08/08/23 |
ASX - By Stock
|
190
|
49K
|
2
|
|
ASX - By Stock
|
PER |
Re:
James Garner AKA JG
|
|
yolt
|
190 |
49K |
4 |
08/08/23 |
08/08/23 |
ASX - By Stock
|
190
|
49K
|
4
|
|
ASX - By Stock
|
PER |
Re:
James Garner AKA JG
|
|
yolt
|
190 |
49K |
1 |
08/08/23 |
08/08/23 |
ASX - By Stock
|
190
|
49K
|
1
|
|
ASX - By Stock
|
KZA |
Re:
top 20
|
|
yolt
|
27 |
10K |
6 |
08/08/23 |
08/08/23 |
ASX - By Stock
|
27
|
10K
|
6
|
|
ASX - By Stock
|
KZA |
Re:
top 20
|
|
yolt
|
27 |
10K |
6 |
05/08/23 |
05/08/23 |
ASX - By Stock
|
27
|
10K
|
6
|
|
ASX - By Stock
|
KZA |
Re:
Comparisions other Drug Companies
|
|
yolt
|
6 |
2.5K |
3 |
03/08/23 |
03/08/23 |
ASX - By Stock
|
6
|
2.5K
|
3
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Paxalisib receives Fast Track Designation from US FDA
|
|
yolt
|
42 |
13K |
3 |
27/07/23 |
27/07/23 |
ASX - By Stock
|
42
|
13K
|
3
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Proposed issue of securities - KZA
|
|
yolt
|
10 |
3.0K |
6 |
17/07/23 |
17/07/23 |
ASX - By Stock
|
10
|
3.0K
|
6
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Paxalisib receives Fast Track Designation from US FDA
|
|
yolt
|
42 |
13K |
5 |
11/07/23 |
11/07/23 |
ASX - By Stock
|
42
|
13K
|
5
|
|